Riskpilot← Back to searchSign inGet full accessVitalyze AB
ABActiveOrg 5591993133Östermalmsgatan 93General medical practice activities · NACE 8621Est. 20190 employees
Revenue 2023
SEK 963K
+142% vs 2022
EBITDA margin
-7.2%
-157% vs 2022
Equity ratio
-44.0%
Financial strength
Net profit 2023
SEK -116K
-276% vs 2022
| Revenue | SEK 963K | +142% |
| EBITDA | SEK -69K | -157% |
| Net profit | SEK -116K | -276% |
| Total assets | SEK 147K | -51% |
| Equity | SEK -64K | -153% |
| Employees | 0 | — |
Legal name
Vitalyze AB
Org number
5591993133
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
19 mars 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva hälsovård och därmed förenlig verksamhet.
Address
Östermalmsgatan 93
Email
amandastark.md@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 83 | 188 | 398 | 963 |
| Staff expenses | — | — | — | −203 | −734 |
| EBITDA | −22 | −23 | 15 | 122 | −69 |
| Depreciation & amort. | −0 | −0 | −45 | −45 | −45 |
| EBIT | −22 | −23 | −30 | 77 | −114 |
| Net financials | — | — | −2 | −1 | −2 |
| Profit before tax | −22 | −23 | −32 | 76 | −116 |
| Tax | −0 | −0 | −0 | −10 | — |
| Net profit | −22 | −23 | −32 | 66 | −116 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 28 | 61 | 115 | 296 | 147 |
| Equity | 28 | 25 | 106 | 122 | −64 |
| Long-term debt | 0 | 0 | 0 | 11 | 7 |
| Short-term debt | 0 | 36 | 9 | 163 | 204 |
| Total debt | — | 36 | 9 | 175 | 211 |
EBITDA margin
-7.2%
This company
15.8%
Market median
-146% vs market
20192023
Equity ratio
-44.0%
This company
38.2%
Market median
-215% vs market
20192023
Return on equity
-11629300.0%
This company
18.4%
Market median
-63202817% vs market
20192023
Net profit margin
-12.1%
This company
8.1%
Market median
-249% vs market
20192023
Asset turnover
6.57×
This company
1.12×
Market median
+487% vs market
20192023
Debt / equity
3.27×
This company
0.62×
Market median
-427% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-03-01 – 2019-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vitalyze AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ebba Amanda Stark | Board of Directors | 0 companies |
| Ratheesh Kelamparambil Mani | Deputy Board Member | 0 companies |
| Robert Stig Ivar Hållstrand | Deputy Board Member | 0 companies |